Keywords
Multiple Sclerosis
central nervous system
biopharmaceutics
biological therapy
biomarkers
microbiota
hematopoietic stem cell transplantation
central nervous system
biopharmaceutics
biological therapy
biomarkers
microbiota
hematopoietic stem cell transplantation
How to Cite
Biotechnology applied to health: the case of Multiple Sclerosis. PART 1. (2018). Biochemistry and Clinical Pathology Journal, 82(3), 34-42. https://doi.org/10.62073/bypc.v82i3.93
Abstract
Multiple Sclerosis is a central nervous system chronic disease that until now has no curative treatment. In this paper, we review the contributions of biotechnology to the diagnosis, treatment and detection of new therapeutic targets of this complex pathology.